WallachBeth Capital LLC, a leading provider of capital markets and institutional execution services, announced today that Bone Biologics Corporation (NASDAQ:BBLG), a developer of orthobiologic products for spine fusion, announced the pricing of an underwritten public offering of 3,777,778 units at an offering price of $1.35 per unit, for total gross proceeds of $5,100,000 before deducting underwriting discounts and commissions and other offering expenses.
Henry Schein Gears Up For Q3 Print; Here’s A Look At Recent Price Target Changes By The Most Accurate Analysts
Henry Schein, Inc. (NASDAQ: HSIC) is projected to release financial results for its third quarter, before the opening bell on Nov. 13, 2023.
